Pfizer Inc and BioNTech could secure emergency US and European authorization for their COVID-19 vaccine next month after final trial results showed it had a 95% success rate and no serious side...
from NDTV News - Special https://ift.tt/2INuQfK
from NDTV News - Special https://ift.tt/2INuQfK
Comments
Post a Comment